HeartSciences Inc.
HSCS
$3.46
$0.113.28%
NASDAQ
01/31/2025 | 10/31/2024 | 07/31/2024 | 04/30/2024 | 01/31/2024 | |
---|---|---|---|---|---|
Revenue | -- | -- | -- | 0.00 | 14.70K |
Total Other Revenue | -- | -- | -- | -- | -- |
Total Revenue | -- | -- | -- | 0.00 | 14.70K |
Cost of Revenue | -- | -- | -- | 0.00 | 4.60K |
Gross Profit | -- | -- | -- | 0.00 | 10.10K |
SG&A Expenses | 1.34M | 786.10K | 850.70K | 833.70K | 1.03M |
Depreciation & Amortization | -- | -- | -- | -- | -- |
Other Operating Expenses | -- | -- | -- | -- | -- |
Total Operating Expenses | 2.37M | 1.99M | 2.08M | 1.88M | 1.54M |
Operating Income | -2.37M | -1.99M | -2.08M | -1.88M | -1.53M |
Income Before Tax | -2.54M | -2.08M | -2.05M | -1.85M | -1.64M |
Income Tax Expenses | -- | -- | -- | -- | -- |
Earnings from Continuing Operations | -2.54M | -2.08M | -2.05M | -1.85M | -1.64M |
Earnings from Discontinued Operations | -- | -- | -- | -- | -- |
Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
Minority Interest in Earnings | -- | -- | -- | -- | -- |
Net Income | -2.54M | -2.08M | -2.05M | -1.85M | -1.64M |
EBIT | -2.37M | -1.99M | -2.08M | -1.88M | -1.53M |
EBITDA | -2.37M | -1.97M | -2.06M | -1.87M | -1.52M |
EPS Basic | -2.57 | -2.27 | -2.64 | -2.82 | -3.01 |
Normalized Basic EPS | -1.61 | -1.42 | -1.65 | -1.76 | -1.88 |
EPS Diluted | -2.57 | -2.27 | -2.64 | -2.82 | -3.01 |
Normalized Diluted EPS | -1.61 | -1.42 | -1.65 | -1.76 | -1.88 |
Average Basic Shares Outstanding | 986.10K | 917.40K | 777.70K | 654.10K | 546.70K |
Average Diluted Shares Outstanding | 986.10K | 917.40K | 777.70K | 654.10K | 546.70K |
Dividend Per Share | -- | -- | -- | -- | -- |
Payout Ratio | -- | -- | -- | -- | -- |